Lesaffre strengthens its Research, Development & Innovation (RD&I) with the acquisition of Altar, a company owned by Ginkgo Bioworks

"At Lesaffre, we are driven by an unwavering belief in the infinite possibilities of fermentation," says Brice-Audren Riché, CEO of Lesaffre. "Powered by the incredible potential of microorganisms, we see fermentation as a transformative solution to nourish a growing global population in a safer, healthier, and more sustainable way. As a leader in bioengineering and bioprocesses, we naturally place research, development, and innovation at the heart of our success. Our strong commitment to R&D reflects our mission to better nourish and protect our planet. In recent years, this dedication has only intensified, as evidenced by our strategic investments. First, we established the Lesaffre Campus — a state-of-the-art hub designed to accelerate innovation leveraging the latest architectural and technological advancements. Additionally, we have bolstered our R&D capabilities through the strategic acquisition of three companies specializing in fermentation research over the past three years."

France, 07/10/2024 (informazione.it - comunicati stampa - salute e benessere)

This deal includes Lesaffre's integration of Altar's team, its know-how and the machines designed and used by the teams daily. This technology, mastered by its users for years now, is a real asset for Lesaffre, complementing its existing range of technologies. The deal has been closed at the end of September 2024 .

This acquisition of skills and know-how complements the existing technologies of the Lesaffre Institute of Science and Technology (LIST) and is part of its strategy to invest more and more in its RD&I equipment to best meet the needs of the Group's customers. Thanks to this technology, Lesaffre will be able to offer its clients more complex strains and improve the high quality of their products.

Based in Evry (Ile-de- France ) within Genopole, the first French Biocluster dedicated to biotechnology, Altar's 14 employees are integrated within Lesaffre Institute of Science and Technology, the RD&I department of Lesaffre. They constitute a real force for the Group, which relies on their knowledge and expertise of this technology to push the boundaries of innovation further.

A key global player in fermentation for more than a century, Lesaffre, with a 3 billion euros turnover, and established on all continents, counts 11,000 employees and 96 nationalities. On the strength of this experience and diversity, we work with customers, partners and researchers to find ever more relevant answers to the needs of food, health, naturalness and respect for our environment. Thus, every day, we explore and reveal the infinite potential of microorganisms.

To nourish 9 billion people, in a healthy way, in 2050 by making the most of our planet's resources is a major and unprecedented issue. We believe that fermentation is one of the most promising answers to this challenge.

More information on  www.lesaffre.com
Join us in conversation on LinkedIn and on Twitter

Press contact:
 

 

View original content: https://www.prnewswire.co.uk/news-releases/lesaffre-strengthens-its-research-development--innovation-rdi-with-the-acquisition-of-altar-a-company-owned-by-ginkgo-bioworks-302268640.html